- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 239/96 - Two oxygen atoms
Patent holdings for IPC class C07D 239/96
Total number of patents in this class: 132
10-year publication summary
|
13
|
16
|
6
|
4
|
8
|
10
|
15
|
8
|
5
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| IMPACT Therapeutics, Inc. | 35 |
11 |
| Shandong Cynda Chemical Co., Ltd. | 11 |
4 |
| Ajinomoto Co., Inc. | 2314 |
3 |
| Takeda Pharmaceutical Company Limited | 2945 |
3 |
| EA Pharma Co., Ltd. | 84 |
3 |
| Ludwig Institute for Cancer Research Ltd | 188 |
3 |
| Technion Research & Development Foundation Ltd. | 1196 |
3 |
| Impact Therapeutics (Shanghai), Inc | 45 |
3 |
| Novartis AG | 11289 |
2 |
| Glaxosmithkline Intellectual Property Development Limited | 737 |
2 |
| Consejo Superior de Investigaciones Cientificas | 909 |
2 |
| Emory University | 1586 |
2 |
| Gilead Sciences, Inc. | 1951 |
2 |
| Omeros Corporation | 297 |
2 |
| Ranbaxy Laboratories Limited | 358 |
2 |
| Shin Poong Pharmaceutical Co., Ltd. | 40 |
2 |
| Shionogi & Co., Ltd. | 889 |
2 |
| Southern Research Institute | 211 |
2 |
| Rambam Med-Tech Ltd. | 76 |
2 |
| Sanofi | 3935 |
2 |
| Other owners | 75 |